In a Perspective, Stephen Tang and Samuel Sternberg discuss retroelement-based gene editing as a safer alternative to CRISPR-Cas approaches.
Pharmalittle: We’re reading about Medicare negotiations, U.K. drug rebates rising, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was refreshing and reassuring. After all, that oh-so-familiar routine of phone